- South Africa’s medicines regulator, the South African Health Products Regulatory Authority (Sahpra), has approved a two-monthly anti-HIV injection. At the Emavundleni Prevention Research Centre in Nyanga outside Cape Town, more than 200 women have been taking the jab as part of a clinical trial.
- The shot almost entirely cancels people’s chances of contracting HIV through sex. It’s also easier to stick to than the daily HIV prevention pill because it only has to be taken once every two months.
- Our reporters travelled to Cape Town and spoke to three women who’ve become HIV prevention advocates in their communities. Watch the video to find out why they’re worried about getting the virus. They also tell us how the injection, called CAB-LA, has changed their lives.
- Read the full script here.
- READ MORE: If the price is right: The anti-HIV jab could be in clinics by August 2023
Mohale Moloi worked at Bhekisisa as a television producer and health journalist from July 2021 to March 2024.
Jessica Pitchford is Bhekisisa's TV and multimedia editor. She's been a journalist since the early nineties and has reported on some pivotal events in South Africa’s political history, such as the country’s transition to democracy and the work of the Truth & Reconciliation Commission.
